MedPath

Efficacy of Smartphone App for Smoking Cessation in China

Not Applicable
Completed
Conditions
Smartphone App-based Smoking Cessation
Cigarette Smoking
Interventions
Behavioral: smartphone app for smoking cessation
Registration Number
NCT04421170
Lead Sponsor
Sir Run Run Shaw Hospital
Brief Summary

This study aims to evaluate the efficacy of cognitive behavioral therapy (CBT)-based cigarette smoking cessation smartphone app for treatment seeking smokers in China.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1289
Inclusion Criteria
  1. Cigarette smokers (smoked more than 100 cigarettes in their lifetime, and currently smoke five or more cigarettes a day)
  2. 25 years of age or older
  3. Being able to read and write in Chinese
  4. Owning a smartphone
  5. Have experience of using apps
  6. Expressing an interest in quitting smoking within the next month
  7. Willing to provide informed consent to participate in the study
Exclusion Criteria
  1. Nonsmokers
  2. Only use electronic cigarettes
  3. Smokers without attempts to quit smoking
  4. Participants with severe mental illness
  5. Participants who had already started their quit attempt or using any smoking cessation treatment at the time of registration
  6. Unable to use smartphone and apps
  7. Unable to read and write in Chinese

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention Groupsmartphone app for smoking cessationParticipants from the intervention group will receive CBT based smoking cessation. It provides both mandatory information of evidence-based and guideline-based smoking cessation interventions, and optional information about quitting benefits, tips for quitting et al. The app will be available for the participants in the intervention group until 26-week post-quit date follow-up. After this period, the app will automatically stop the data collection, but they can continue to use it if they want. As the participants progressed through the study, smoking cessation related information will be gradually reduced until 12 weeks after quit date, and follow-up messages will be sent at 16, 20 and 26 weeks after quit date. Participants from intervention group can also seek for help at any time by text or WeChat, or make a phone call.
Primary Outcome Measures
NameTimeMethod
Biologically verified continuously smoking abstinence at week 2626 weeks

Participants in this study will be considered to be biologically verified continuously smoking abstinence if they report smoking no more than 5 cigarettes since the quit date and have an expired carbon monoxide concentration of less than 10 ppm (for local participants who will be able to go to the PI affiliated hospital) or a urine cotinine cutoff point of 200 ng/ml (cotinine urine dipsticks will be mailed to each participant's address, and test will be confirmed by video call and by family members) at week 26 (6 months) after quit date. This abstinence has been applied by the Society for Research on Nicotine and Tobacco (SRNT) (Hughes, Keely et al. 2003) and the 'Russell Standard' (West, Hajek et al. 2005).

Secondary Outcome Measures
NameTimeMethod
Self-reported continuous smoking abstinence26 weeks

Self-reported continuous smoking abstinence: a self-report of smoking ≤ 5 cigarettes from the past 1, 2, 3, 4, 8, 12, 16, 20 and 26 weeks.

Reductions in number of cigarettes smoked per day26 weeks

Reductions in number of cigarettes smoked per day: will be assessed by comparing the number of cigarettes smoked per day at baseline and at 26 weeks. Cigarettes smoked per day: number of cigarettes smoked per day within seven days or the approximate total number of smoked cigarettes within seven days if not smoked daily.

7-day point prevalence smoking abstinence26 weeks

7-day Point prevalence of smoking abstinence: not even a puff of smoke, for the last seven consecutive days, at 1, 2, 3, 4, 8, 12, 16, 20 and 26 weeks.

Trial Locations

Locations (1)

Yanhui Liao

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath